ArticleJCEM case reports2025
Diabetes as an Initial Presentation of Intraductal Papillary Mucinous Neoplasm.
Article in JCEM case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This is a case of an older man with no prior history of diabetes presenting with a combination of diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS) in the setting of new-onset diabetes mellitus. His further work-up revealed intraductal papillary mucinous neoplasm (IPMN) on pancreatic imaging. Though his diabetes etiology could be multifactorial, it is possible that it is an initial presentation of IPMN. Data have been suggestive of diabetes mellitus associated with degree of dysplasia and worse prognosis of IPMN but the exact pathophysiology behind this is unknown, and it is unclear whether diabetes mellitus is an early presentation of IPMN. We discuss possible differential diagnoses needed to evaluate patients for possible triggers behind DKA and etiologies behind new-onset diabetes mellitus when indicated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.